Inhibition of expression of beta-lactamase using esters of fatty

Details Inhibition of expression of beta-lactamase using esters of fatty Inhibition of expression of beta-lactamase using esters of fatty

1993-05-13

1995-11-14

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514546, 514547, 514558, 514560, A61K 3143, A61K 3122, A61K 31225, A61K 3120

Patent

active

054666856

ABSTRACT:
A class of chemical compounds comprising fatty acid ester derivatives used to inhibit beta-lactamase production by infectious bacteria. These inhibitors have been found to retard the resistance of certain strains of bacteria to beta-lactam antibiotics, such as penicillin, by interfering with the transcription of the beta-lactamase gene and precluding expression of beta-lactamase. In accordance therewith, these inhibitors permit effective treatment of infections of otherwise resistive bacteria with antibiotics.

REFERENCES:
Biosis Abstract of Journal of Antibiotics. (1981).
Biosis Abstract of Journal of Food Prot. (1992).

Affiliated with

Also associated with

Rating

Inhibition of expression of beta-lactamase using esters of fatty does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of expression of beta-lactamase using esters of fatty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of expression of beta-lactamase using esters of fatty will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1221055